These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28888575)

  • 1. Fascaplysin inhibit ovarian cancer cell proliferation and metastasis through inhibiting CDK4.
    Chen S; Guan X; Wang LL; Li B; Sang XB; Liu Y; Zhao Y
    Gene; 2017 Nov; 635():3-8. PubMed ID: 28888575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the GSK-3β inhibitor (2Z,3E)-6-bromoindirubin-3'-oxime upon ovarian cancer cells.
    Yu AS; Zhao L
    Tumour Biol; 2016 Apr; 37(4):4857-64. PubMed ID: 26526575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2 and CCND1/CDK4 expression levels predict the cellular effects of mTOR inhibitors in human ovarian carcinoma.
    Aguirre D; Boya P; Bellet D; Faivre S; Troalen F; Benard J; Saulnier P; Hopkins-Donaldson S; Zangemeister-Wittke U; Kroemer G; Raymond E
    Apoptosis; 2004 Nov; 9(6):797-805. PubMed ID: 15505422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinase inhibitor screening identifies CDK4 as a potential therapeutic target for melanoma.
    Mahgoub T; Eustace AJ; Collins DM; Walsh N; O'Donovan N; Crown J
    Int J Oncol; 2015 Sep; 47(3):900-8. PubMed ID: 26201960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of REG Iα Enhances the Sensitivity to 5-Fluorouracil of Colorectal Cancer Cells via Cyclin D1/CDK4 Pathway and BAX/BCL-2 Pathways.
    Wang Y; Liu X; Liu J; Zhang T
    Cancer Biother Radiopharm; 2019 Aug; 34(6):362-370. PubMed ID: 30973271
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines.
    Benitez DA; Pozo-Guisado E; Alvarez-Barrientos A; Fernandez-Salguero PM; Castellón EA
    J Androl; 2007; 28(2):282-93. PubMed ID: 17050787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of PC cell-derived growth factor (PCDGF)/granulin-epithelin precursor (GEP) decreased cell proliferation and invasion through downregulation of cyclin D and CDK4 and inactivation of MMP-2.
    Liu Y; Xi L; Liao G; Wang W; Tian X; Wang B; Chen G; Han Z; Wu M; Wang S; Zhou J; Xu G; Lu Y; Ma D
    BMC Cancer; 2007 Jan; 7():22. PubMed ID: 17261172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the WWOX gene on the regulation of the cell cycle and apoptosis in human ovarian cancer stem cells.
    Yan H; Tong J; Lin X; Han Q; Huang H
    Mol Med Rep; 2015 Aug; 12(2):1783-8. PubMed ID: 25891642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fascaplysin, a selective CDK4 inhibitor, exhibit anti-angiogenic activity in vitro and in vivo.
    Lin J; Yan XJ; Chen HM
    Cancer Chemother Pharmacol; 2007 Mar; 59(4):439-45. PubMed ID: 16816972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ara-c induces cell cycle G1/S arrest by inducing upregulation of the INK4 family gene or directly inhibiting the formation of the cell cycle-dependent complex CDK4/cyclin D1.
    Sun F; Li N; Tong X; Zeng J; He S; Gai T; Bai Y; Liu L; Lu K; Shen J; Han M; Lu C; Dai F
    Cell Cycle; 2019 Sep; 18(18):2293-2306. PubMed ID: 31322047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine induces cell cycle arrest and apoptosis via cyclinD1/Cdk4 and Bcl-2/Bax pathways in human ovarian cancer cell line OVCAR-3.
    Shirali S; Aghaei M; Shabani M; Fathi M; Sohrabi M; Moeinifard M
    Tumour Biol; 2013 Apr; 34(2):1085-95. PubMed ID: 23345014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cancer cell growth by cyclin dependent kinase 4 inhibitors synthesized based on the structure of fascaplysin.
    Mahale S; Aubry C; Jenkins PR; Maréchal JD; Sutcliffe MJ; Chaudhuri B
    Bioorg Chem; 2006 Oct; 34(5):287-97. PubMed ID: 16904725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epac1 knockdown inhibits the proliferation of ovarian cancer cells by inactivating AKT/Cyclin D1/CDK4 pathway in vitro and in vivo.
    Gao M; Ma Y; Bast RC; Li Y; Wan L; Liu Y; Sun Y; Fang Z; Zhang L; Wang X; Wei Z
    Med Oncol; 2016 Jul; 33(7):73. PubMed ID: 27277757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells.
    Masamha CP; Benbrook DM
    Cancer Res; 2009 Aug; 69(16):6565-72. PubMed ID: 19638577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanism underlying the anticancer effect of simvastatin on MDA-MB-231 human breast cancer cells.
    Shen YY; Yuan Y; Du YY; Pan YY
    Mol Med Rep; 2015 Jul; 12(1):623-30. PubMed ID: 25738368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells.
    Chuang TC; Hsu SC; Cheng YT; Shao WS; Wu K; Fang GS; Ou CC; Wang V
    Cancer Lett; 2011 Dec; 311(1):11-9. PubMed ID: 21757288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells.
    Kim HS; Lee WJ; Lee SW; Chae HW; Kim DH; Oh Y
    Horm Metab Res; 2010 Mar; 42(3):165-72. PubMed ID: 19960406
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Qiu ZH; Zhang WW; Zhang HH; Jiao GH
    World J Gastroenterol; 2019 May; 25(20):2463-2472. PubMed ID: 31171890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A3 adenosine receptor agonist induce G1 cell cycle arrest via Cyclin D and cyclin-dependent kinase 4 pathways in OVCAR-3 and Caov-4 cell lines.
    Joshaghani HR; Jafari SM; Aghaei M; Panjehpour M; Abedi H
    J Cancer Res Ther; 2017; 13(1):107-112. PubMed ID: 28508842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Icariin regulates the proliferation and apoptosis of human ovarian cancer cells through microRNA-21 by targeting PTEN, RECK and Bcl-2.
    Li J; Jiang K; Zhao F
    Oncol Rep; 2015 Jun; 33(6):2829-36. PubMed ID: 25845681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.